IRIS

To identify the prognostic variables relative to myopic choroidal neovascularization (CNV) treated with intravitreal ranibizumab/bevacizumab.

FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION / Iacono, Pierluigi; Battaglia Parodi, Maurizio; Selvi, Federico; Parravano, Maria Cristina; Chiaravalloti, Adele; Varano, Monica; Bandello, Francesco. - In: RETINA. - ISSN 0275-004X. - 37:10(2017), pp. 1931-1941-1941. [10.1097/IAE.0000000000001436]

FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION

Battaglia Parodi, Maurizio;Bandello, Francesco
2017-01-01

Abstract

To identify the prognostic variables relative to myopic choroidal neovascularization (CNV) treated with intravitreal ranibizumab/bevacizumab.
2017
Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Intravitreal Injections; Male; Middle Aged; Myopia, Degenerative; Prognosis; Prospective Studies; Ranibizumab; Refraction, Ocular; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/80538
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 16
social impact